{"id":"https://openalex.org/W2049593278","doi":"https://doi.org/10.1016/j.pain.2013.03.006","title":"Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain","display_name":"Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-13","ids":{"openalex":"https://openalex.org/W2049593278","doi":"https://doi.org/10.1016/j.pain.2013.03.006","mag":"2049593278","pmid":"https://pubmed.ncbi.nlm.nih.gov/23628600"},"language":"en","primary_location":{"id":"doi:10.1016/j.pain.2013.03.006","doi":"https://doi.org/10.1016/j.pain.2013.03.006","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pain.2013.03.006","pdf_url":null,"source":{"id":"https://openalex.org/S140848990","display_name":"Pain","issn_l":"0304-3959","issn":["0304-3959","1872-6623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2049593278"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082669130","display_name":"Alan Kivitz","orcid":"https://orcid.org/0000-0002-1045-1310","observed_orcids":["https://orcid.org/0000-0002-1045-1310"]},"institutions":[{"id":"https://openalex.org/I4210112965","display_name":"Altoona Center for Clinical Research","ror":"https://ror.org/022q8ez38","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210112965"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alan J. Kivitz","raw_affiliation_strings":["Altoona Center for Clinical Research, Duncansville, PA 16635, USA. ajkivitz@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altoona Center for Clinical Research, Duncansville, PA 16635, USA. ajkivitz@yahoo.com","institution_ids":["https://openalex.org/I4210112965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083878086","display_name":"Joseph S Gimbel","orcid":"https://orcid.org/0000-0002-6254-2417","observed_orcids":["https://orcid.org/0000-0002-6254-2417"]},"institutions":[{"id":"https://openalex.org/I4210122658","display_name":"Arizona Research Center","ror":"https://ror.org/022fhzr29","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210122658"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph S. Gimbel","raw_affiliation_strings":["Arizona Research Center, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Research Center, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210122658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043138248","display_name":"Candace Bramson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Candace Bramson","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111773460","display_name":"Mary Anne Nemeth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary Anne Nemeth","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103329228","display_name":"D.S. Keller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David S. Keller","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020554337","display_name":"M. Brown","orcid":"https://orcid.org/0000-0002-8310-4774","observed_orcids":["https://orcid.org/0000-0002-8310-4774"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark T. Brown","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089760100","display_name":"Christine R. West","orcid":"https://orcid.org/0000-0001-9447-2911","observed_orcids":["https://orcid.org/0000-0001-9447-2911"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christine R. West","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084258579","display_name":"Kenneth M. Verburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth M. Verburg","raw_affiliation_strings":["Pfizer Inc.Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc.Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082669130"],"corresponding_institution_ids":["https://openalex.org/I4210112965"],"apc_list":null,"apc_paid":null,"fwci":13.6514,"has_fulltext":false,"cited_by_count":156,"citation_normalized_percentile":{"value":0.99191587,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"154","issue":"7","first_page":"1009","last_page":"1021"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.33469998836517334,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11840","display_name":"Pain Management and Treatment","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tanezumab","display_name":"tanezumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-low-back-pain","display_name":"chronic low back pain","score":0.9319999814033508},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9169999957084656},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8880000114440918},{"id":"https://openalex.org/keywords/pain-intensity","display_name":"pain intensity","score":0.7820000052452087},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.8379999995231628},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8669999837875366},{"id":"https://openalex.org/keywords/joint-pain","display_name":"joint pain","score":0.968999981880188},{"id":"https://openalex.org/keywords/paresthesia","display_name":"paresthesia","score":0.9160000085830688},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.9099498987197876},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.7547067403793335},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7095947265625},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7072589993476868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6426177620887756},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49639445543289185},{"id":"https://openalex.org/C2781118164","wikidata":"https://www.wikidata.org/wiki/Q1088113","display_name":"Chronic pain","level":2,"score":0.46016925573349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4161776006221771},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32936960458755493},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2923038601875305},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.2179798185825348},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05920189619064331},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009288","descriptor_name":"Naproxen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017116","descriptor_name":"Low Back Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017116","descriptor_name":"Low Back Pain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059350","descriptor_name":"Chronic Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D059350","descriptor_name":"Chronic Pain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.pain.2013.03.006","doi":"https://doi.org/10.1016/j.pain.2013.03.006","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pain.2013.03.006","pdf_url":null,"source":{"id":"https://openalex.org/S140848990","display_name":"Pain","issn_l":"0304-3959","issn":["0304-3959","1872-6623"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"journal-article"},{"id":"pmid:23628600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23628600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pain","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W186123574","https://openalex.org/W1495436755","https://openalex.org/W1567484043","https://openalex.org/W1822035430","https://openalex.org/W1965622444","https://openalex.org/W1969646198","https://openalex.org/W1975659610","https://openalex.org/W1978358625","https://openalex.org/W1984742195","https://openalex.org/W1985803081","https://openalex.org/W1993390942","https://openalex.org/W1994174812","https://openalex.org/W2001401457","https://openalex.org/W2003034438","https://openalex.org/W2016178396","https://openalex.org/W2019559069","https://openalex.org/W2024172570","https://openalex.org/W2029662381","https://openalex.org/W2053508422","https://openalex.org/W2057928029","https://openalex.org/W2059524959","https://openalex.org/W2067689995","https://openalex.org/W2078160818","https://openalex.org/W2083908960","https://openalex.org/W2087110004","https://openalex.org/W2089232660","https://openalex.org/W2091349116","https://openalex.org/W2095484690","https://openalex.org/W2095995963","https://openalex.org/W2106755981","https://openalex.org/W2106903173","https://openalex.org/W2113709332","https://openalex.org/W2118432230","https://openalex.org/W2124239698","https://openalex.org/W2134905207","https://openalex.org/W2139158348","https://openalex.org/W2145513209","https://openalex.org/W2145843622","https://openalex.org/W2185006473","https://openalex.org/W2315358369","https://openalex.org/W2316771461","https://openalex.org/W2916774960","https://openalex.org/W3194956376","https://openalex.org/W4245219653","https://openalex.org/W4249507143","https://openalex.org/W4290308554"],"related_works":["https://openalex.org/W2091349116","https://openalex.org/W3120227962","https://openalex.org/W1997383797","https://openalex.org/W3093433847","https://openalex.org/W3027729271","https://openalex.org/W1971447338","https://openalex.org/W4312094113","https://openalex.org/W3124601147","https://openalex.org/W2789263604","https://openalex.org/W4291214487"],"abstract_inverted_index":{"Tanezumab":[0,102,127],"is":[1],"a":[2,13],"humanized":[3],"monoclonal":[4],"antibody":[5],"that":[6],"specifically":[7],"inhibits":[8],"nerve":[9],"growth":[10],"factor":[11],"as":[12],"treatment":[14,191],"for":[15,29],"chronic":[16,30,234],"pain.":[17,101,237],"This":[18],"phase":[19],"IIB":[20],"study":[21],"investigated":[22],"the":[23,88,171,196],"efficacy":[24,57,108],"and":[25,36,93,104,110,118,124,137,168,194,224,229],"safety":[26],"of":[27,98,131,143,189],"tanezumab":[28,42,154,190,202,216],"low":[31,66,99,235],"back":[32,67,100,236],"pain":[33,68,164],"vs":[34,121,134,145,227],"placebo":[35,123,135,146,160,228],"naproxen.":[37,162],"Patients":[38],"(N=1347)":[39],"received":[40],"intravenous":[41],"(5,":[43],"10,":[44],"or":[45,53,161],"20mg":[46,105,203],"every":[47],"8weeks),":[48],"naproxen":[49,125,138,230],"(500mg":[50],"twice":[51],"daily),":[52],"placebo.":[54],"The":[55,180],"primary":[56],"end":[58,77],"point":[59],"was":[60,151,199,210],"mean":[61,80],"change":[62,81],"in":[63,87,140,165,187,221,231],"daily":[64],"average":[65],"intensity":[69],"(LBPI)":[70],"from":[71,82],"baseline":[72,83],"to":[73,84],"week":[74,85],"16.":[75],"Secondary":[76],"points":[78],"included":[79],"16":[86],"Roland":[89,114],"Morris":[90,115],"Disability":[91,116],"Questionnaire":[92],"Patient's":[94],"Global":[95],"Assessment":[96],"(PGA)":[97],"10":[103],"had":[106],"similar":[107,211],"profiles":[109],"significantly":[111,218],"improved":[112],"LBPI,":[113],"Questionnaire,":[117],"PGA":[119,132],"scores":[120,133,226],"both":[122],"(P\u2a7d.05).":[126,147],"5mg":[128],"provided":[129,217],"improvement":[130,142,220],"(P\u2a7d.05),":[136],"resulted":[139],"significant":[141],"LBPI":[144],"Adverse":[148],"event":[149,208],"incidence":[150,209],"comparable":[152],"across":[153,212],"doses":[155],"but":[156],"higher":[157],"than":[158],"with":[159,201,233],"Arthralgia,":[163],"extremity,":[166],"headache,":[167],"paresthesia":[169],"were":[170,192],"most":[172,181],"commonly":[173],"reported":[174,183],"adverse":[175,184,207],"events":[176,185],"by":[177],"tanezumab-treated":[178],"patients.":[179],"frequently":[182],"resulting":[186],"discontinuation":[188],"arthralgia":[193],"paresthesia;":[195],"highest":[197],"frequency":[198],"observed":[200],"(both":[204],"1.4%).":[205],"Serious":[206],"treatments.":[213],"In":[214],"conclusion,":[215],"greater":[219],"pain,":[222],"function,":[223],"global":[225],"patients":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2049593278","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":21},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
